The OPA Professional Practice, Spotlight and Important Update emails inform members of pharmacy trends, membership benefits, OPA’s advocacy work, changes to regulations as well as clinical tools and resources to support pharmacy professionals in their careers. This collection provides members with access to previous editions of emails. The information contained in the emails is subject to change and was current at the time the publication was shared.

2022 Publications

November

Association Highlights

  • Join the Opioid and Pain Management in Pharmacy Program Advisory Group

Pharmacy Resources

  • Pharmacy Safety and Security – Robbery Prevention In-Person Event
  • How Pharmacists Can Improve Outcomes in Patients with Diabetes — Blog Post
  • Moderna Spikevax Bivalent COVID-19 Vaccine FAQ

Membership Benefits

  • Don’t Miss Your Exclusive OPA Member Discount – Get 15% Off Pharmacist’s Letter Canada! 
  • RxVigilance—Clinical and Reference Software

Professional Development News

  • Improving the Management of Diabetes in Insulin-Dependent Patients Webinar Series
  • Limited Time Offer—Save on the Prescribing for Minor Ailments – The Fundamentals Course

View the Publication

On November 8th, 2022, the Ministry of Health released updated Executive Officer (EO) Notices related to the COVID-19 vaccine program in Ontario. Highlights of updates to the EO notices and accompanying guidance documents include…

View the Publication

Consultations and Submissions

  • OPA’s Proposal on Minor Ailment Funding
  • OPA’s Recommendations on Policy Priorities

COVID-19 Vaccine Administration

  • FAQs on COVID-19 Vaccine Booster Doses
    COVaxON Updates
  • COVID-19 Testing

COVID-19 PCR Testing in Ontario Pharmacies

  • Pharmacy Programs
  • UIIP Program Reminders
  • McKesson Memo on Influenza Vaccine Orders

ODB and Third-Party Payor Program Updates

  • ODB Formulary Updates

Pharmacy News

  • Discount on OPA’s Minor Ailment Course
  • Access to Archived OPA Email Communications
  • OCP Survey on Time Delayed Safes

View the Publication

October

Association Highlights

  • OPA’s Guide to Pharmacy Safety: Increase Safety Measures and Take Preventative Actions

Pharmacy Resources

  • Blog Post — A Decade of Immunizations: Pharmacy Professionals and Vaccinations
  • Canadian Patient Safety Week
  • Upcoming Webinars

Membership Benefit

  • Win 1 of 2 Pharmacy Technician OPA Memberships with Relief Buddy!

View the Publication

COVID-19 Vaccine Administration

  • COVaxON Updates

COVID-19 Testing

  • Updates to OPA’s COVID-19 PCR Testing Documentation Form
    Pharmacy Programs
    UIIP Program Reminders

Pharmacy Programs

  • UIIP Program Reminders

ODB and Third-Party Payor Program Updates

  • Sun Life Transition from Telus/Assure to ESC Canada
Pharmacy Webinars
  • Evusheld: Preventing COVID-19 in High-Risk Patients Webinar
  • Eliminating Cervical Cancer – Diagnosis and Treatment of Cervical Cancer
Pharmacy News
  • Health Canada Issues Statement on Pediatric Tylenol and Advil Shortage
  • Health Products Stewardship Association Educational Materials on Medication Disposal 
  • OPA Pharmacy Safety Tools 
  • OPA Website Scheduled Maintenance

View the Publication

Today the Ontario government announced that effective Monday October 17th, 2022, individuals 12 years of age and older will be eligible for a booster dose of the Pfizer Bivalent vaccine. The Ministry is recommending that individuals receive the bivalent booster 6 months (168 days) after their previous COVID-19 vaccine. However, with informed consent, individuals may receive a booster dose of the bivalent vaccine after 3 months…

View the Publication

Association Highlights

  • Pharmacogenetics: The Future of Patient Care Signature Learning Series
  • Pillar of Pharmacy Award

Pharmacy Resources

  • Blog Post — The Current Landscape of Compounding Pharmacy
  • Evusheld: Preventing COVID-19 in High-Risk Patients
  • ICYMI: Webinar Recordings

Insurance Update

  • Manulife Term Life Insurance Plan

View the Publication

The Ministry of Health has updated the Executive Officer Notices related to COVID-19 testing in Ontario pharmacies. The updates have been made to align with the most recent changes to the COVID-19 Provincial Testing Guidance…

View the Publication

COVID-19 Vaccine Administration

  • Updated OPA Moderna Spikevax COVID-19 Tool

Pharmacy Programs

  • OPA’s UIIP Consent and Screening Form Now Available
  • Ordering Process for the 2022/2023 UIIP Season
  • UIIP Tools and Resources

ODB and Third-Party Payor Program Updates

  • ODB Formulary Updates

Pharmacy News

  • Flu Shots, COVID Boosters, and Immunizations Webinar
  • Updated Features: SADIE

View the Publication

On October 3rd, 2022, the Ministry of Health released Executive Officer Notices on patient access to publicly funded Evusheld through Ontario pharmacies…

View the Publication

September

Association Highlights

  • Board Meeting Update
  • Health Care Provider and Patient Resources for New Methadone Products

Pharmacy Resources

  • National Day for Truth and Reconciliation
  • Blog Post––– The Pharmacist’s Role in Prevention of HPV-Related Cancers
  • Key Findings from CPhA’s National Flu Shot Survey
  • Apotex APOthecary Heroes Contest

Membership Benefits

  • Relief Buddy is Giving Away Two Pharmacy Technician Memberships
  • Venngo Summer Giveaway Winners

View the Publication

Today the Ministry of Health released updated Executive Officer Notices related to the COVID-19 vaccine program in Ontario…

View the Publication

COVID-19 Vaccine Administration

  • Reminder: Moderna Bivalent Vaccine Eligibility Expansion
  • COVID-19 Vaccines in Pregnancy and Breastfeeding
  • New Formulation of the Pediatric Pfizer COVID-19 Vaccine

COVaxON Updates

  • Inventory Production Defect in COVaxON

ODB and Third-Party Payor Program Updates

  • Scheduled HNS and NMS Outage
  • Update on the Adjudication Service for La Capitale/Beneva

Pharmacy News

  • World Pharmacists Day
  • OPA Pharmacy Safety Tools
  • Blog Post— An Inside Look into Professional
  • Affairs at OPA: A Pharmacy Student’s Perspective
  • Updated Shingrix Indication
  • Specialty Pharmacy Summit

View the Publication

On September 20th, 2022, the Ministry of Health released Executive Officer Notices regarding the Administration of Publicly Funded Influenza Vaccines in Ontario Pharmacies. Since the inception of the UIIP pharmacy program in 2012, pharmacists have played a crucial role in vaccinating Ontarians against the influenza virus…

View the Publication

Association Highlights

  • OPA Pharmacy Student Job Opportunity Available!

Pharmacy Resources

  • Protecting the Population Against COVID-19 Signature Learning Series
  • Focus on Osteoporosis Therapeutic Option
  • Upcoming Webinar— Keeping Your Pharmacy and Staff Safe from Robberies
  • Research Study: Recruiting Health Care Providers for a Medical Cannabis Survey

View the Publication

Today the Ontario government, in consultation with the Chief Medical Officer of Health, announced the eligibility criteria for booster doses of the Moderna bivalent vaccine. The rollout of the vaccination campaign will consist of two phases, with the bivalent vaccine becoming available to high-priority demographics first, followed by expansion to a wider group of individuals…

View the Publication

As Ontario continues to manage the COVID-19 virus, the province is expanding access for Moderna Bivalent to community pharmacies. Effective September 9th, 2022, McKesson is allowing for ordering of the Moderna Bivalent vaccine outside of the normal prebook process. As vaccine program expansion typically begins with priority populations, pharmacy professionals should consider the anticipated demand for this demographic within their community when placing initial orders…

View the Publication

COVID-19 Vaccine Administration

  • Health Canada Authorizes Bivalent COVID-19 Vaccines
  • Pre-Book Orders of the Moderna Bivalent Vaccine
  • COVID-19 Executive Officer Notices on Vaccines

Pharmacy Programs

  • UIIP 2022/2023 Implementation Materials

ODB and Third-Party Payor Program Updates

  • New Methadone Product Added to the Monitored Drug List

Pharmacy News

  • OCP Announces Requirements for Minor Ailments Prescribing Course
  • The Ontario Pharmacists Association Condemns Acts of Violence Against Pharmacy Professionals
  • Pharmacy Student Opportunity Available
  • Upcoming Complimentary Webinars

View the Publication